NovaRock Biotherapeutics
PrivateLast Round
Corporate Funding
Aug 25, 2021
Total Funding Raised
$7.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NovaRock Biotherapeutics is a biotechnology company that develops antibody therapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaRock Biotherapeutics Comparables
Compare NovaRock Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qure Biotechnology (Shanghai) Co., Ltd. | 80% | |
| I-Mab Biopharma | 77% | |
| Keymed Biosciences | 76% |
NovaRock Biotherapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- May 14, 2026
Monthly visitors increased 56% MoM.
NovaRock Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovaRock Biotherapeutics's valuation, stock price, and market status.
Is NovaRock Biotherapeutics a public or private company?
NovaRock Biotherapeutics is a private company.
What is the current stock price of NovaRock Biotherapeutics?
NovaRock Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks NovaRock Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovaRock Biotherapeutics worth (valuation)?
Valuation information for NovaRock Biotherapeutics is not publicly available.
Can I buy NovaRock Biotherapeutics stock?
NovaRock Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovaRock Biotherapeutics's last funding round?
NovaRock Biotherapeutics's most recent funding round was Corporate Funding on August 25, 2021.
Who are the main investors in NovaRock Biotherapeutics?
Investor information for NovaRock Biotherapeutics is not publicly disclosed.
Will NovaRock Biotherapeutics IPO soon?
No public IPO plans have been announced for NovaRock Biotherapeutics.
How can I track NovaRock Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NovaRock Biotherapeutics's shares on secondary markets.